Buy this Article for $7.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Authors

  1. Aschenbrenner, Diane S. MS, RN

Abstract

* A new cephalosporin, ceftaroline fosamil (Teflaro), has been approved to treat acute bacterial skin infections caused by methicillin-resistant Staphylococcus aureus, as well as serious community-acquired bacterial pneumonia requiring hospitalization.

 

* Ceftaroline fosamil is administered as an IV infusion.